These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16837817)

  • 1. Erythropoietin in experimental acute renal failure.
    Sharples EJ; Yaqoob MM
    Nephron Exp Nephrol; 2006; 104(3):e83-8. PubMed ID: 16837817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model.
    Spandou E; Tsouchnikas I; Karkavelas G; Dounousi E; Simeonidou C; Guiba-Tziampiri O; Tsakiris D
    Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
    Heitrich M; García DM; Stoyanoff TR; Rodríguez JP; Todaro JS; Aguirre MV
    Biomed Pharmacother; 2016 Aug; 82():606-13. PubMed ID: 27470403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of erythropoietin attenuates kidney injury induced by ischemia/reperfusion with increased activation of Wnt/β-catenin signaling.
    Chen X; Wang CC; Song SM; Wei SY; Li JS; Zhao SL; Li B
    J Formos Med Assoc; 2015 May; 114(5):430-7. PubMed ID: 25682558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and acute renal failure.
    Sharples EJ; Yaqoob MM
    Semin Nephrol; 2006 Jul; 26(4):325-31. PubMed ID: 16949472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1alpha.
    Imamura R; Moriyama T; Isaka Y; Namba Y; Ichimaru N; Takahara S; Okuyama A
    Transplantation; 2007 May; 83(10):1371-9. PubMed ID: 17519789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin protects against ischaemic acute renal injury.
    Vesey DA; Cheung C; Pat B; Endre Z; Gobé G; Johnson DW
    Nephrol Dial Transplant; 2004 Feb; 19(2):348-55. PubMed ID: 14736958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin attenuates apoptosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic Wister rats.
    Caetano AM; Vianna Filho PT; Castiglia YM; Golim MA; de Souza AV; de Carvalho LR; Deffune E; de Oliveira C; Vianna PT
    Transplant Proc; 2011 Dec; 43(10):3618-21. PubMed ID: 22172815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of lipopolysaccharide-induced acute kidney injury by erythropoietin: involvement of mitochondria-regulated apoptosis.
    Stoyanoff TR; Todaro JS; Aguirre MV; Zimmermann MC; Brandan NC
    Toxicology; 2014 Apr; 318():13-21. PubMed ID: 24561306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.
    Johnson DW; Pat B; Vesey DA; Guan Z; Endre Z; Gobe GC
    Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erythropoietin on mesenchymal stem cell differentiation and secretion in vitro in an acute kidney injury microenvironment.
    Liu NM; Tian J; Wang WW; Han GF; Cheng J; Huang J; Zhang JY
    Genet Mol Res; 2013 Feb; 12(4):6477-87. PubMed ID: 23479159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased progression to kidney fibrosis after erythropoietin is used as a treatment for acute kidney injury.
    Gobe GC; Bennett NC; West M; Colditz P; Brown L; Vesey DA; Johnson DW
    Am J Physiol Renal Physiol; 2014 Mar; 306(6):F681-92. PubMed ID: 24402097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events.
    van Rijt WG; van Goor H; Ploeg RJ; Leuvenink HG
    Transpl Int; 2014 Mar; 27(3):241-8. PubMed ID: 23964738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure.
    Nemoto T; Yokota N; Keane WF; Rabb H
    Kidney Int; 2001 Jan; 59(1):246-51. PubMed ID: 11135077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin pretreatment ameliorates renal ischaemia-reperfusion injury by activating PI3K/Akt signalling.
    Zhang J; Zou YR; Zhong X; Deng HD; Pu L; Peng K; Wang L
    Nephrology (Carlton); 2015 Apr; 20(4):266-72. PubMed ID: 25581532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin ameliorates renal ischemia and reperfusion injury via inhibiting tubulointerstitial inflammation.
    Hu L; Yang C; Zhao T; Xu M; Tang Q; Yang B; Rong R; Zhu T
    J Surg Res; 2012 Jul; 176(1):260-6. PubMed ID: 21816412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat.
    Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Yang BY; Lee MY; Sol MY
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S170-5. PubMed ID: 19194548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury.
    Sølling C; Christensen AT; Krag S; Frøkiaer J; Wogensen L; Krog J; Tønnesen EK
    Acta Anaesthesiol Scand; 2011 Feb; 55(2):185-95. PubMed ID: 21226860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.
    Sharples EJ; Patel N; Brown P; Stewart K; Mota-Philipe H; Sheaff M; Kieswich J; Allen D; Harwood S; Raftery M; Thiemermann C; Yaqoob MM
    J Am Soc Nephrol; 2004 Aug; 15(8):2115-24. PubMed ID: 15284297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney.
    Gong H; Wang W; Kwon TH; Jonassen T; Li C; Ring T; FrøkiAEr J; Nielsen S
    Kidney Int; 2004 Aug; 66(2):683-95. PubMed ID: 15253723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.